HPV Vaccine: Protect Against Cervical Cancer & Genital Warts

Health officials are emphasizing the importance of vaccination against the Human Papillomavirus (HPV) as a preventative measure against cervical cancer and genital warts. Certain types of HPV are identified as the primary cause of cervical cancer, a prevalent cancer among women globally.

HPV Explained

The virus spreads through direct contact and can be transmitted by someone carrying the virus, even if they show no symptoms. Infection with some HPV types can develop into cervical cancer in women over time. Men can also be carriers of the virus or develop genital warts, making vaccination a crucial preventative step for both sexes.

Did You Know? HPV is a leading cause of cervical cancer, one of the most common cancers affecting women worldwide.

Currently, two types of vaccines are available. One is specifically for women to prevent cervical cancer, while the other protects both women and men against genital warts and cervical cancer. Vaccination can begin as early as age 9, with the number of doses – two or three – determined by the individual’s age when vaccination starts.

Vaccination centres

Health authorities confirm the vaccine is both safe and effective, but recommend postponing vaccination if a fever is present or during pregnancy. The vaccine is available through Vacsera (Serum and Vaccine) vaccination centres, and citizens are encouraged to utilize this resource to protect themselves and their children from future health complications.

Expert Insight: Proactive vaccination against HPV represents a significant public health strategy, addressing a virus with the potential for serious long-term consequences for both men and women. The availability of vaccines targeting both cancer prevention and wart protection underscores the broad benefits of this preventative measure.

Frequently Asked Questions

How is HPV transmitted?

HPV is transmitted through direct contact.

At what age can vaccination begin?

Vaccination can begin as early as age 9.

Where is the vaccine available?

The vaccine is available through Vacsera (Serum and Vaccine) vaccination centres.

If vaccination schedules are followed and access to vaccines remains consistent, we may see a continued decline in HPV-related illnesses. However, ongoing monitoring and public health campaigns will likely be necessary to maintain high vaccination rates. A possible next step could be expanded outreach programs to ensure equitable access to vaccination for all populations.